---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-001211"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T09:54:07.950040+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma agrees to reduce warrant exercise price to $0.40 for 1.03M shares, raising $412k

## Summary
- Lind Global Fund exercises 1,029,167 warrants at reduced price of $0.40/share, generating $411,666.80 in proceeds.
- The company agrees to a 15-day standstill on further common stock issuances, with exceptions for employee plans and strategic transactions.
- Resale of the underlying shares is already registered on Form S-1 (File 333-280411).
- Company reimburses $3,000 of Holder's legal fees, withheld from exercise proceeds.

## SEC filing metadata
- accession: 0001213900-25-001211
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390025001211/0001213900-25-001211-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025001211/ea0226487-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-001211
- JSON: https://secwatch.observer/filing/0001213900-25-001211.json
- Plain text: https://secwatch.observer/filing/0001213900-25-001211.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.